The Effectiveness of Family History Questionnaires in Cancer Genetic Counseling

被引:20
作者
Armel, Susan Randall [1 ]
McCuaig, Jeanna [1 ]
Finch, Amy [1 ]
Demsky, Rochelle [1 ]
Panzarella, Tony [2 ]
Murphy, Joan [1 ]
Rosen, Barry [1 ]
机构
[1] Princess Margaret Hosp, Familial Breast & Ovarian Canc Clin, Toronto, ON M5G 2M9, Canada
[2] Princess Margaret Hosp, Dept Biostat, Toronto, ON M5G 2M9, Canada
关键词
Genetic counseling; Family history; Hereditary breast and ovarian cancer; Probability estimate; BREAST-CANCER; OVARIAN-CANCER; BRCA2; MUTATIONS; RISKS; PREVALENCE; SERIES; PENETRANCES; VALIDATION; CARRIERS; WOMEN;
D O I
10.1007/s10897-009-9228-x
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
The number of individuals receiving genetic counseling for hereditary breast and ovarian cancer syndrome has steadily risen. To triage patients for genetic counseling and to help reduce the amount of time needed by a genetic counselor in direct patient contact, many clinics have implemented the use of family history questionnaires. Although such questionnaires are widely used, scant literature exists evaluating their effectiveness. This article explores the extent to which family history questionnaires are being used in Ontario and addresses the utility of such questionnaires in one familial cancer clinic. By comparing the pedigrees created from questionnaires to those updated during genetic counseling, the accuracy and effectiveness of the questionnaires was explored. Of 121 families recruited into the study, 12% acquired changes to their pedigree that led to a revised probability estimate for having a BRCA1 or BRCA2 mutation and 5% acquired changes that altered their eligibility for genetic testing. No statistically significant difference existed between the eligibility for genetic testing prior to and post counseling. This suggests that family history questionnaires can be effective at obtaining a family history and accurately assessing eligibility for genetic testing. Based on the variables that were significantly associated with a change in probability estimate, we further present recommendations for improving the clarity of such questionnaires and therefore the ease of use by patients.
引用
收藏
页码:366 / 378
页数:13
相关论文
共 19 条
[1]   Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history:: A combined analysis of 22 studies [J].
Antoniou, A ;
Pharoah, PDP ;
Narod, S ;
Risch, HA ;
Eyfjord, JE ;
Hopper, JL ;
Loman, N ;
Olsson, H ;
Johannsson, O ;
Borg, Å ;
Pasini, B ;
Radice, P ;
Manoukian, S ;
Eccles, DM ;
Tang, N ;
Olah, E ;
Anton-Culver, H ;
Warner, E ;
Lubinski, J ;
Gronwald, J ;
Gorski, B ;
Tulinius, H ;
Thorlacius, S ;
Eerola, H ;
Nevanlinna, H ;
Syrjäkoski, K ;
Kallioniemi, OP ;
Thompson, D ;
Evans, C ;
Peto, J ;
Lalloo, F ;
Evans, DG ;
Easton, DF .
AMERICAN JOURNAL OF HUMAN GENETICS, 2003, 72 (05) :1117-1130
[2]   BRCAPRO validation, sensitivity of genetic testing of BRCA1/BRCA2, and prevalence of other breast cancer susceptibility genes [J].
Berry, DA ;
Iversen, ES ;
Gudbjartsson, DF ;
Hiller, EH ;
Garber, JE ;
Peshkin, BN ;
Lerman, C ;
Watson, P ;
Lynch, HT ;
Hilsenbeck, SG ;
Rubinstein, WS ;
Hughes, KS ;
Parmigiani, G .
JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (11) :2701-2712
[3]  
Breast Canc Linkage Consortium, 1999, JNCI-J NATL CANCER I, V91, P1310
[4]  
Brener D., 1996, American Journal of Human Genetics, V59, pA333
[5]   Information and support needs of women with primary relatives with breast cancer: development of the Information and Support Needs Questionnaire [J].
Chalmers, KI ;
Luker, KA ;
Leinster, SJ ;
Ellis, I ;
Booth, K .
JOURNAL OF ADVANCED NURSING, 2001, 35 (04) :497-507
[6]  
*FAMYGENETIX LTD, 2001, CYR 3
[7]   RISKS OF CANCER IN BRCA1-MUTATION CARRIERS [J].
FORD, D ;
EASTON, DF ;
BISHOP, DT ;
NAROD, SA ;
GOLDGAR, DE ;
HAITES, N ;
MILNER, B ;
ALLAN, L ;
PONDER, BAJ ;
PETO, J ;
SMITH, S ;
STRATTON, M ;
LENOIR, GM ;
FEUNTEUN, J ;
LYNCH, H ;
ARASON, A ;
BARKARDOTTIR, R ;
EGILSSON, V ;
BLACK, DM ;
KELSELL, D ;
SPURR, N ;
DEVILEE, P ;
CORNELISSE, CJ ;
VARSEN, H ;
BIRCH, JM ;
SKOLNICK, M ;
SANTIBANEZKOREF, MS ;
TEARE, D ;
STEEL, M ;
PORTER, D ;
COHEN, BB ;
CAROTHERS, A ;
SMYTH, E ;
WEBER, B ;
NEWBOLD, B ;
BOEHNKE, M ;
COLLINS, FS ;
CANNONALBRIGHT, LA ;
GOLDGAR, D .
LANCET, 1994, 343 (8899) :692-695
[8]  
HALLOWELL N, 1997, BMJ CLIN RES ED, V281, P7076
[9]   Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2 [J].
King, MC ;
Marks, JH ;
Mandell, JB .
SCIENCE, 2003, 302 (5645) :643-646
[10]   Penetrances of breast and ovarian cancer in a large series of families tested for BRCA1/2 mutations [J].
Marroni, F ;
Aretini, P ;
D'Andrea, E ;
Caligo, MA ;
Cortesi, L ;
Viel, A ;
Ricevuto, E ;
Montagna, M ;
Cipollini, G ;
Federico, M ;
Santarosa, M ;
Marchetti, P ;
Bailey-Wilson, JE ;
Bevilacqua, G ;
Parmigiani, G ;
Presciuttini, S .
EUROPEAN JOURNAL OF HUMAN GENETICS, 2004, 12 (11) :899-906